Adar1 Capital Management, LLC Royalty Pharma PLC Transaction History

Adar1 Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2024 Feb 13, 2025	SELL	$24.28 - $28.39 $25.4 Million - $29.7 Million	-1,046,703 Reduced 95.44%	49,963 $1.27 Billion
Q3 2024 Nov 14, 2024	SELL	$25.63 - $29.27 $2.17 Million - $2.48 Million	-84,666 Reduced 7.17%	1,096,666 $31 Billion
Q2 2024 Aug 13, 2024	BUY	$26.26 - $29.9 $12.1 Million - $13.8 Million	460,031 Added 63.78%	1,181,332 $31.2 Billion
Q1 2024 May 15, 2024	SELL	$27.46 - $31.33 $16.5 Million - $18.8 Million	-600,533 Reduced 45.43%	721,301 $21.9 Billion
Q4 2023 Feb 14, 2024	BUY	$26.21 - $29.22 $34.6 Million - $38.6 Million	1,321,834 New	1,321,834 $37.1 Billion

496

306M

1.99M

384K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $15.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Adar1 Capital Management, LLC with notifications on news.